| Active ingredient (INN) | Norepinephrine Bitartrate In |
|---|---|
| Therapeutic category | Auto-created by FDA Drug Enforcement — Full Recall Database scraper |
| Controlled substance | No |
|---|
| Marketing-authorisation holders | WG Critical Care, LLC, SANDOZ CANADA INCORPORATED, STERIMAX INC, BAXTER CORPORATION +1 more |
|---|
| Registrations on file | 8 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Norepinephrine Bitartrate In Sodium Chloride | .016mg/mL | injection | 🇺🇸 US | WG Critical Care, LLC | Active |
| Norepinephrine Bitartrate In Sodium Chloride | .032mg/mL | injection | 🇺🇸 US | WG Critical Care, LLC | Active |
| Norepinephrine Bitartrate In Sodium Chloride | .064mg/mL | injection | 🇺🇸 US | WG Critical Care, LLC | Active |
| Norepinephrine Bitartrate In Sodium Chloride | .128mg/mL | injection | 🇺🇸 US | WG Critical Care, LLC | Active |
| Norepinephrine Bitartrate Injection Usp | — | solution | 🇨🇦 CA | SANDOZ CANADA INCORPORATED | Active |
| Norepinephrine Bitartrate Injection, Usp | — | solution | 🇨🇦 CA | STERIMAX INC | Active |
| Norepinephrine Bitartrate In 5% Dextrose | 5% | solution | 🇨🇦 CA | BAXTER CORPORATION | Active |
| Norepinephrine Bitartrate | — | solution | 🇨🇦 CA | JUNO PHARMACEUTICALS CORP. | Active |